Laspobres, Jye Rileigh A.
HRN: 15-76-31 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2022
CEFUROXIME 750MG (VIAL)
12/20/2022
12/27/2022
IVTT
600mg
Q8
PCAP
Waiting Final Action